Skip to main content
Pradeep Natarajan, MD, Cardiology, Boston, MA

PradeepNatarajanMDMMSc

Cardiology • Boston, MA

Preventive Cardiology, Cardiovascular Disease Genetics

Director of Preventive Cardiology at Massachusetts General Hospital

Join to view full profile

Dr. Natarajan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Natarajan's full profile

Already have an account?

  • Office

    55 Fruit Street
    Boston, MA 02114
    Phone+1 617-726-2000

Education & Training

  • Harvard Medical School
    Harvard Medical SchoolMMSc, Biomedical Informatics, 2013 - 2015
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 2011 - 2015
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2011
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2008 - 2009
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2008
  • University of California, Berkeley
    University of California, BerkeleyBA, Molecular & Cell Biology, Honors, 2000 - 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2025
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical Utility of Lipoprotein(A) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease  
    Pradeep Natarajan, MD, JAMA Cardiology
  • Completing the Genetic Spectrum Influencing Coronary Artery Disease: From Germline to Somatic Variation  
    Pradeep Natarajan, MD, Cardiovascular Research
  • Recall by Genotype and Cascade Screening for Familial Hypercholesterolemia in a Population-Based Biobank from Estonia  
    Sekar Kathiresan, Pradeep Natarajan, Nature
  • Join now to see all

Press Mentions

  • Blood Pressure Patterns Differ Between South Asian and East Asian Adults in UK
    Blood Pressure Patterns Differ Between South Asian and East Asian Adults in UKFebruary 12th, 2025
  • Research Reveals Distinct Blood Pressure Patterns in South Asian and East Asian Adults
    Research Reveals Distinct Blood Pressure Patterns in South Asian and East Asian AdultsFebruary 11th, 2025
  • 22 Health Care Predictions for 2025 from Medical Researchers
    22 Health Care Predictions for 2025 from Medical ResearchersDecember 31st, 2024
  • Join now to see all

Grant Support

  • Exploration and benchmarking of duplex sequencingBROAD INSTITUTE, INC.2023–2028
  • Exploration and benchmarking of duplex sequencingBROAD INSTITUTE, INC.2023–2028
  • Exploration and benchmarking of duplex sequencingBROAD INSTITUTE, INC.2023–2028
  • Exploration and benchmarking of duplex sequencingBROAD INSTITUTE, INC.2023–2028
  • Exploration and benchmarking of duplex sequencingBROAD INSTITUTE, INC.2023–2028
  • Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemiasMASSACHUSETTS GENERAL HOSPITAL2019–2028
  • Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemiasMASSACHUSETTS GENERAL HOSPITAL2019–2028
  • Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemiasMASSACHUSETTS GENERAL HOSPITAL2019–2028
  • Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemiasMASSACHUSETTS GENERAL HOSPITAL2019–2028
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMedEMORY UNIVERSITY2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMedEMORY UNIVERSITY2023–2027
  • Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMedEMORY UNIVERSITY2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMedEMORY UNIVERSITY2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
  • Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South AsiansMASSACHUSETTS GENERAL HOSPITAL2021–2026
  • Clonal hematopoiesis in humans: determinants of development and progressionBAYLOR COLLEGE OF MEDICINE2019–2025
  • Using genetic variation to study biology of blood lipids & coronary heart diseaseBOSTON UNIVERSITY MEDICAL CAMPUS2015–2025
  • Using genetic variation to study biology of blood lipids & coronary heart diseaseBOSTON UNIVERSITY MEDICAL CAMPUS2015–2025
  • Using genetic variation to study biology of blood lipids & coronary heart diseaseBOSTON UNIVERSITY MEDICAL CAMPUS2015–2025
  • Using genetic variation to study biology of blood lipids & coronary heart diseaseBOSTON UNIVERSITY MEDICAL CAMPUS2015–2025

Professional Memberships

Dr. Pradeep Natarajan, Dr. Pradeep Natarajan, MD, Dr. P Natarajan